Tianxiu Liu

机构：Fujian Medical University, Union Hospital

发表论文 15 篇 · 总被引 151 次 · h-index 7

代表论文

• Prognostic significance of platelet-to-albumin ratio in patients with esophageal squamous cell carcinoma receiving definitive radiotherapy (2022 · Scientific Reports · 被引 39)
• Factors associated with immunotherapy respond and survival in advanced non-small cell lung cancer patients (2021 · Translational Oncology · 被引 27)
• Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation (2021 · BMC Cancer · 被引 17)
• A Nutrition-Related Factor-Based Risk Stratification for Exploring the Clinical Benefits in the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: A Retrospective Cohort Study (2022 · Frontiers in Nutrition · 被引 14)
• Cost-Effectiveness Analysis of Camrelizumab Immunotherapy versus Docetaxel or Irinotecan Chemotherapy as Second-Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (2021 · Cancer Management and Research · 被引 14)
• Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma (2021 · Radiation Oncology · 被引 14)